1
Sept 25 (Reuters) – The US Food and Drug Administration has approved AbbVie's drug for Parkinson's disease in adults, the health regulator's website showed on Friday. (Reporting by Kamal Choudhury in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)